[PDF][PDF] Recurrent MiscarriageGreen‐top Guideline No. 17.

L Regan, R Rai, S Saravelos… - BJOG: An International …, 2023 - missionmrcog.com
• In this guideline, recurrent miscarriage has been defined as three or more first trimester
miscarriages. However, clinicians are encouraged to use their clinical discretion to …

The role of acetylsalicylic acid in the prevention of pre-Eclampsia, fetal growth restriction, and Preterm birth

J Stubert, B Hinz, R Berger - Deutsches Ärzteblatt International, 2023 - pmc.ncbi.nlm.nih.gov
Background Recent studies suggest that low-dose acetylsalicylic acid (ASA) can lower
pregnancy-associated morbidity. Methods This review is based on pertinent publications …

Cytokine imbalance at materno-embryonic interface as a potential immune mechanism for recurrent pregnancy loss

S Ali, S Majid, MN Ali, S Taing, MU Rehman… - International …, 2021 - Elsevier
Recurrent pregnancy loss (RPL) is a prominent reproductive disease that distresses about
2%-5% of couples. RPL is the loss of two or more successive spontaneous pregnancies …

Management of antiphospholipid syndrome

A Ghembaza, D Saadoun - Biomedicines, 2020 - mdpi.com
Antiphospholipid syndrome (APS), is an acquired autoimmune disorder characterised by
thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL) …

[PDF][PDF] Current management of recurrent pregnancy loss

MR Chester, A Tirlapur… - The Obstetrician & …, 2022 - researchgate.net
The management of recurrent pregnancy loss (RPL) is a challenging clinical scenario with
associated psychological trauma. It can be frustrating for both patients and clinicians. It is …

Inherited thrombophilia and anticoagulant therapy for women with reproductive failure

AR Han, JW Han, SK Lee - American Journal of Reproductive …, 2021 - Wiley Online Library
Reproductive failure (RF) is the inability to conceive or to carry a pregnancy to term, and its
prevalence is not negligible. Pregnancy is a prothrombotic condition, which can be …

Antiphospholipid syndrome

M Petri - Translational Research, 2020 - Elsevier
Antiphospholipid syndrome is one of the more common acquired causes of
hypercoagulability. Its major presentations are thrombotic (arterial, venous, or …

[HTML][HTML] Management of thromboembolic disorders during pregnancy in resource-constrained settings: An Indian perspective

C Singh, A Jain, R Tandon… - Indian Journal of Medical …, 2023 - journals.lww.com
Venous thromboembolism (VTE) in pregnancy and resulting thrombotic disorders are
increasingly being recognized as an important cause of maternal morbidity and mortality …

Risk factors for pregnancy morbidity in women with antiphospholipid syndrome

J Yang, M Liang - Journal of Reproductive Immunology, 2021 - Elsevier
Antiphospholipid syndrome (APS) increases the risk of obstetric complications, but risk
factors for pregnancy morbidity in women with APS remain incompletely characterized. This …

Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis

ML Urban, A Bettiol, I Mattioli, G Emmi… - Internal and Emergency …, 2021 - Springer
Women with criteria and non-criteria obstetric antiphospholipid syndrome (APS) carry an
increased risk of pregnancy complications, including fetal growth restriction (FGR). The …